Workshop tackles challenges in biomarker and drug development

A commentary published online 23 October in the Journal of the National Cancer Institute summarises a set of critical decision points in cancer biomarker and drug development. The points, which emerged from a workshop, include developing a clear understanding of the biology of the target and its interaction with the drug and the factors affecting the performance of the biomarker assay...

Read the whole article on

More from